Fig. 2From: Exploring the relationships between hormone receptor, HER2 status, and bone involvement in the first distant metastases of in Chinese breast cancer patients who lacked HER2 targeted therapyStratified logistic regression analysis on bone involvement at distant metastasis (DM). HR + / − hormone receptor-positive/negative, HER2 + / − human epidermal growth factor receptor 2-positive/negative, ET + / − endocrine therapy full/non or partial compliance status. The final covariates included BC diagnosis age, diagnosis calendar year after 2010, tumor laterality, tumor quadrant, T stage, N stage, tumor pathology, tumor grade, LVI, chemotherapy, RT, and categorical disease-free timeBack to article page